Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Loxo Oncology, Inc.Listing unverified | Buy | $5.5K | conv 49ClusterFirst in 12mo | SEC | |
Loxo Oncology, Inc.Listing unverified | Buy | $5.4M | conv 51ClusterFirst in 12mo | SEC | |
Loxo Oncology, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Loxo Oncology, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Loxo Oncology, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Durata Therapeutics, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Durata Therapeutics, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |